March 2022

WCHQ Launches Initiative to Improve CKD Care

Chronic kidney disease can be a devastating and costly illness. Early identification and treatment are critically important. WCHQ launched a new initiative February 16 aimed at reducing the disease burden of CKD through measurement and improvement. The project is supported by Bayer. A recording of the February 16 CKD Launch Event is here (passcode bb0+JQ#B). See the media announcement.

The initiative leverages WCHQ’s expertise in data collection, measurement and quality improvement with Bayer’s expertise in CKD. WCHQ’s member health systems will provide input into the selection and development of relevant clinical measures and actively test the usefulness of the metrics in the clinical setting. The resultant data will inform quality improvement efforts in health systems statewide.

WCHQ President and CEO Gabrielle Rude, PhD, said the project will have a far-reaching impact on the diagnosis of and treatment for CKD.

“WCHQ is unique in the health care environment because we collect data and then use it to monitor and drive quality improvement among our member health systems,” Dr. Rude said. “This project is focused on finding better ways to identify, prevent and treat chronic kidney disease and then share what we learn with practitioners across the country.”

WCHQ is now recruiting health care professionals from our member organizations who have a professional or personal interest in CKD to serve on a new WCHQ Statewide CKD Advisory Group. This group will be comprised of nephrologists, primary care physicians, advance practice professionals, nutritionists, quality improvement professionals, population health managers, epidemiologists, diabetes and hypertension educators, and representatives from provider-owned health plans who have an interest in improving the quality and affordability of care for those with CKD.  

The Advisory Group will start meeting in late March. This group will determine the direction of this statewide initiative including the selection of measures. The Advisory Group will also foster opportunities for shared learning and identify topics to include in a statewide education summit on CKD for WCHQ members.  

The opportunity to participate on the Advisory Group is open to any one associated with a WCHQ member organization. Contact Sheryl Pierce and please share the announcement with colleagues.